secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sabre Corp (SABR)
CIK:        0001597033
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001193125-26-094301
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 1.02, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sabre appoints Constellation Software exec to board; ends poison pill
---------------------------------------------------------------------

- Appoints Damian McKay (CEO Vela Software, Constellation division) to Sabre board; effective within 10 business days.
- Constellation holds ~12.7% of Sabre shares; standstill caps ownership at 15% during specified period.
- Sabre terminates March 1, 2026 shareholder rights plan (poison pill); expiration accelerated to close on March 6, 2026.
- Constellation withdraws prior director nomination notice; parties agree to mutual non-disparagement and confidentiality.
- McKay will serve on Technology Committee; receives annual cash retainer of $90,000 plus equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1597033/000119312526094301/0001193125-26-094301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1597033/000119312526094301/d87762d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-094301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer